Damiano, a professor at Boston University and the chief executive of a promising start-up called Beta Bionics, was there to support a new generation of continuous glucose monitoring technology – part ...
Advanced report intelligence delivers actionable guidance to improve outcomes for people using the iLet Bionic PancreasIRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Beta Bionics today announced ...
Irvine-based Beta Bionics, which recently went public, saw two-year revenue increase more than eight-fold to $103.2 million.
Description: This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a ...
Add Yahoo as a preferred source to see more of our stories on Google. Beta Bionics said it plans to integrate its ILet Bionic Pancreas automated insulin delivery system with a glucose-ketone sensor ...
MANCHESTER, N.H. and GERMANTOWN, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing transformative drug delivery technologies, and ...
(RTTNews) - Beta Bionics, Inc. (BBNX), a commercial-stage medical device company, announced financial results for the fourth quarter of 2025, posting a narrowed net loss and higher revenue compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results